CP

CoStim Pharmaceuticals

Acquired

Immune checkpoint antibodies to unlock the immune system against cancer

Cambridge, United States · Founded 2011

Employees
1–10
Founded
2011
Business Model
B2B
Last Round
Series AJan 2013
Rounds
2
Acquired by
Novartis AGFeb 2014

Indexed holds 3 funding rounds and 5 investors for this company. The full record is or through the API.

About

CoStim Pharmaceuticals was a Cambridge, Massachusetts-based cancer immunotherapy company founded in 2011. The company developed antibody therapeutics targeting immune checkpoint proteins, including PD-1, to harness the immune system against cancer. Its programs were designed to block cancer immune evasion signals and were intended to act as standalone agents or in combination with other therapies. Backed by MPM Capital and Atlas Venture, CoStim raised approximately $10 million in a Series A round before being acquired by Novartis in February 2014 — just 12 months after its Series A — as Novartis sought to enter the PD-1 checkpoint inhibitor race and complement its CAR-T cell therapy program.

Summary

CoStim Pharmaceuticals is a Biotech company based in Cambridge, United States, founded in 2011. Its most recent funding was a Series A round in Jan 2013. Investors include MPM Capital, Novartis Venture Fund and Atlas Venture.

Funding & Exit History

AcquisitionFeb 2014

Sign up to see all 3 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

CoStim Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/costim-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/costim-pharmaceuticals" alt="CoStim Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>